Cost-effectiveness of focal psychodynamic therapy and enhanced cognitive-behavioural therapy in out-patients with anorexia nervosa

Psychological Medicine

Volumn 46, Issue 16, 2016, Pages 3291-3301

  Egger, N ^a   Wild, B ^b   Zipfel, S ^c   Junne, F ^c   Konnopka, A ^a   Schmidt, U ^d   De Zwaan, M ^e   Herpertz, S ^f   Zeeck, A ^g   Lowe B ^a   Von Wietersheim, J ^h   Tagay, S ⁱ   Burgmer, M ^j   Dinkel, A ^k   Herzog, W ^b   Konig H H ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h UNIVERSITY HOSPITAL ULM   (Germany)

ⁱ UNIVERSITY OF DUISBURG ESSEN   (Germany)

^j UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^k TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

Anorexia nervosa; cognitive therapy; cost effectiveness; psychodynamic psychotherapy

Indexed keywords

ADULT; AMBULATORY CARE; ANOREXIA NERVOSA; COGNITIVE THERAPY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; GERMANY; HOSPITALIZATION; HUMAN; PROCEDURES; PSYCHODYNAMIC PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; AMBULATORY CARE; ANOREXIA NERVOSA; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; FEMALE; GERMANY; HOSPITALIZATION; HUMANS; PSYCHOTHERAPY, PSYCHODYNAMIC; YOUNG ADULT;

EID: 84986596659     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291716002002     Document Type: Article

References (40)

1. Abbate-Daga G, Amianto F, Delsedime N, De-Bacco C, Fassino S (2013). Resistance to treatment and change in anorexia nervosa [corrected]: a clinical overview. BMC Psychiatry 13, 294.
2. Abbate-Daga G, Facchini F, Marzola E, Delsedime N, Giovannone C, Amianto F, Fassino S (2014). Health-related quality of life in adult inpatients affected by anorexia nervosa. European Eating Disorders Review 22, 285-291.
3. Ackard DM, Richter S, Egan A, Engel S, Cronemeyer CL (2014). The meaning of (quality of) life in patients with eating disorders: a comparison of generic and disease-specific measures across diagnosis and outcome. International Journal of Eating Disorders 47, 259-267.
4. Azur MJ, Stuart EA, Frangakis C, Leaf PJ (2011). Multiple imputation by chained equations: what is it and how does it work? International Journal of Methods in Psychiatric Research 20, 40-49.
5. Brooks A, Hagen SE, Sathyanarayanan S, Schultz AB, Edington DW (2010). Presenteeism: critical issues. Journal of Occupational and Environmental Medicine 52, 1055-1067.
6. Byford S, Barrett B, Roberts C, Clark A, Edwards V, Smethurst N, Gowers SG (2007). Economic evaluation of a randomised controlled trial for anorexia nervosa in adolescents. British Journal of Psychiatry 191, 436-440.
7. Chisholm D, Knapp MR, Knudsen HC, Amaddeo F, Gaite L, van Wijngaarden B (2000). Client Socio-Demographic and Service Receipt Inventory-European Version: development of an instrument for international research. EPSILON Study 5. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. British Journal of Psychiatry 39, s28-s33.
8. Crow S (2014). The economics of eating disorder treatment. Current Psychiatry Reports 16, 454.
9. de Jong P, Heller GZ (2008). Generalized Linear Models for Insurance Data. Cambridge University Press: Cambridge, UK.
10. Dejong H, Broadbent H, Schmidt U (2012). A systematic review of dropout from treatment in outpatients with anorexia nervosa. International Journal of Eating Disorders 45, 635-647.
11. Deutsche Krankenhausgesellschaft (2009). Bestandsaufnahme zur Krankenhausplanung und Investitionsfinanzierung in den Bundesländern. Deutsche Krankenhausgesellschaft: Berlin.
12. Dolan P (1997). Modeling valuations for Euro Qol health states. Medical Care 35, 1095-1108.
13. Fairburn CG (2008). Cognitive Behavior Therapy and Eating Disorders. The Guilford Press: New York and London.
14. Fenwick E, O?Brien BJ, Briggs A (2004). Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions. Health Economics 13, 405-415.
15. Fichter M, Quadflieg N (2001). The Structured Interview for Anorexic and Bulimic Disorders for DSM-IV and ICD-10 (SIAB-EX): reliability and validity. European Psychiatry 16, 38-48.
16. Friederich HC, Herzog W, Wild B, Zipfel S, Schauenburg H (2014). Anorexia Nervosa. Fokale psychodynamische Psychotherapie. Hogrefe: Göttingen.
17. Graham JW, Olchowski AE, Gilreath TD (2007). How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prevention Science 8, 206-213.
18. Gray AM (2011). Applied Methods of Cost-Effectiveness Analysis in Health Care. Oxford University Press: Oxford.
19. Hoch JS, Briggs AH, Willan AR (2002). Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Economics 11, 415-430.
20. Hoch JS, Rockx MA, Krahn AD (2006). Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of " community acquired" syncope. BMC Health Services Research 6, 68.
21. Kessler RC, Ames M, Hymel PA, Loeppke R, McKenas DK, Richling DE, Stang PE, Ustun TB (2004). Using the World Health Organization Health and Work Performance Questionnaire (HPQ) to evaluate the indirect workplace costs of illness. Journal of Occupational and Environmental Medicine 46, S23-S37.
22. Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B (2005). Empirical standard costs for health economic evaluation in Germany-A proposal by the working group methods in health economic evaluation. Gesundheitswesen 67, 736-746.
23. Legenbauer T, Vocks S (2005). Manual der kognitiven Verhaltenstherapie bei Anorexie und Bulimie. Springer: Berlin.
24. Nan L, Johnson JA, Shaw JW, Coons SJ (2007). A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions. Medical Decision Making 27, 321-326.
25. National Collaborating Centre for Mental Health (2004). National Institute for Health and Clinical Excellence: guidance. In Eating Disorders: Core Interventions in the Treatment and Management of Anorexia Nervosa, Bulimia Nervosa and Related Eating Disorders, pp. 64-65. British Psychological Society: UK, The British Psychological Society & The Royal College of Psychiatrists: Leicester.
26. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P (2001). A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodology 27, 85-95.
27. Rote Liste Service Gmb H (2008). Rote Liste 2008. Arzneimittelverzeichnis für Deutschland. Rote Liste Service Gmb H: Frankfurt am Main.
28. Statistisches Bundesamt (2008). Pflegestatistik 2007. Statistisches Bundsamt: Wiesbaden.
29. Statistisches Bundesamt (2009). Kostennachweis der Krankenhäuser 2008. Statistisches Bundesamt: Wiesbaden.
30. Statistisches Bundesamt (2009). Grunddaten der Krankenhäuser 2008. Statistisches Bundesamt: Wiesbaden.
31. Statistisches Bundesamt (2009). Verdienste und Arbeitskosten. Statistisches Bundesamt: Wiesbaden.
32. Statistisches Bundesamt (2010). Volkswirtschaftliche Gesamtrechnungen 2009. Statistisches Bundesamt:Wiesbaden.
33. Stuhldreher N, Konnopka A, Wild B, Herzog W, Zipfel S, Lowe B, Konig HH (2012). Cost-of-illness studies and cost-effectiveness analyses in eating disorders: a systematic review. International Journal of Eating Disorders 45, 476-491.
34. van Buuren S, Groothuis-Oudshoorn K (2011). mice: Multiple imputation by chained equations in R. Journal of Statistical Software 45, 1-67.
35. Wild B, Friederich HC, Gross G, Teufel M, Herzog W, Giel KE, de Zwaan M, Schauenburg H, Schade-Brittinger C, Schafer H, Zipfel S (2009). The ANTOP study: focal psychodynamic psychotherapy, cognitive-behavioural therapy, and treatment-As-usual in outpatients with anorexia nervosa-A randomized controlled trial. Trials 10, 23.
36. Wu M, Brazier JE, Kearns B, Relton C, Smith C, Cooper CL (2015). Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample. European Journal of Health Economics 16, 141-151.
37. Zerwas S, Larsen JT, Petersen L, Thornton LM, Mortensen PB, Bulik CM (2015). The incidence of eating disorders in a Danish register study: associations with suicide risk and mortality. Journal of Psychiatric Research 65, 16-22.
38. Zethraeus N, Johannesson M, Jonsson B, Lothgren M, Tambour M (2003). Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies. Pharmacoeconomics 21, 39-48.
39. Zipfel S, Giel KE, Bulik CM, Hay P, Schmidt U (2015). Anorexia nervosa: aetiology, assessment, and treatment. Lancet Psychiatry 2, 1099-1111.
40. Zipfel S, Wild B, Gross G, Friederich HC, Teufel M, Schellberg D, Giel KE, de Zwaan M, Dinkel A, Herpertz S, Burgmer M, Löwe B, Tagay S, von Wietersheim J, Zeeck A, Schade-Brittinger C, Schauenburg H, Herzog W; ANTOP study group (2014). Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial. Lancet 383, 127-137.